adenosine monophosphate has been researched along with biguanides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoder, A; Losert, W; Scholz, C | 1 |
Bourron, O; Daval, M; Ferré, P; Foufelle, F; Gautier, JF; Hainault, I; Hajduch, E; Servant, JM | 1 |
2 other study(ies) available for adenosine monophosphate and biguanides
Article | Year |
---|---|
[Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Topics: Adenosine Monophosphate; Administration, Oral; Animals; Biguanides; Blood Glucose; Carbutamide; Depression, Chemical; Dose-Response Relationship, Drug; Glyburide; Hypoglycemic Agents; Injections, Intravenous; Platelet Adhesiveness; Platelet Aggregation; Pyrimidines; Rats; Semicarbazides; Sulfonylurea Compounds; Tolazamide; Tolbutamide | 1975 |
Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adenylate Kinase; Adipocytes; Adipose Tissue; Adrenergic beta-Agonists; Adult; Amino Acid Substitution; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Bariatric Surgery; Biguanides; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Female; Humans; Insulin Resistance; Lipolysis; Overweight; Patient Selection; Ribonucleotides; Serine; Thiazolidinediones; Threonine | 2010 |